Carin M. Van Gelder

Enzyme therapy and immune response in relation to CRIM status: the Dutch experience in classic infantile Pompe disease

Carin M. Van Gelder, Marianne Hoogeveen‐Westerveld, Marian A. Kroos et al. · Journal of Inherited Metabolic Disease · 2014 · 107 citations · Full text

Life Sciences, Immunology, Pediatrics +10

Facial‐muscle weakness, speech disorders and dysphagia are common in patients with classic infantile Pompe disease treated with enzyme therapy

Carin M. Van Gelder, Carine I. van Capelle, Berendine J. Ebbink et al. · Journal of Inherited Metabolic Disease · 2011 · 89 citations · Full text

Health Professions, Neurology, Pediatrics +16

Effects of a higher dose of alglucosidase alfa on ventilator‐free survival and motor outcome in classic infantile Pompe disease: an open‐label single‐center study

Carin M. Van Gelder, Esther Poelman, Iris Plug et al. · Journal of Inherited Metabolic Disease · 2016 · 86 citations · Full text

Pharmacy, Pediatrics, Pharmacotherapy +14

Cognitive outcome of patients with classic infantile Pompe disease receiving enzyme therapy

Berendine J. Ebbink, Femke K. Aarsen, Carin M. Van Gelder et al. · Neurology · 2012 · 74 citations

Medicine, Neurology, Pediatrics +17

Cytokine expression in normal, atopic, and asthmatic subjects using the combination of sputum induction and the polymerase chain reaction.

Carin M. Van Gelder, Peter Thomas, Deborah Yates et al. · Thorax · 1995 · 57 citations · Full text

Life Sciences, Immunology, Clinical Immunology +9